In addition, it has been shown that PPAR-α downregulation is associated with a decrease in antioxidant and anti-inflammatory processes in the brain of patients with AD [59], thus highlighting the systemic nature of the neurodegenerative disease. This evidence concerns the gene PPARA and Alzheimer disease.